Extension Study of ABP-671 in Participants With Gout

Conditions: Gout Interventions: Drug: ABP-671; Drug: Allopurinol Sponsors: Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. Enrolling by invitation

Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials